MA30475B1 - Acides biphenyl carboxyliques substitutes et derives en resultant. - Google Patents
Acides biphenyl carboxyliques substitutes et derives en resultant.Info
- Publication number
- MA30475B1 MA30475B1 MA31395A MA31395A MA30475B1 MA 30475 B1 MA30475 B1 MA 30475B1 MA 31395 A MA31395 A MA 31395A MA 31395 A MA31395 A MA 31395A MA 30475 B1 MA30475 B1 MA 30475B1
- Authority
- MA
- Morocco
- Prior art keywords
- derivatives
- carboxylic acids
- substituted biphenyl
- biphenyl carboxylic
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/40—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/42—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
- C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
- C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
La présente invention a pour objet des composés présentant la formule générale (I), les définitions de X, Y, R1,R.2, R3, R4 R9, et R10 données ci-dessous, et/ou un sel ou ester en dérivant. De plus la présente invention a pour objet l'emploi desdits composés pour le traitement de la maladie d'Alzheimer et leur emploi pour la modulation de l'activité de (gamma)-sécrétase.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06112938A EP1849762B1 (fr) | 2006-04-21 | 2006-04-21 | Acides biphényl carboxyliques substitués et leurs dérivés |
Publications (1)
Publication Number | Publication Date |
---|---|
MA30475B1 true MA30475B1 (fr) | 2009-06-01 |
Family
ID=36688012
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA31395A MA30475B1 (fr) | 2006-04-21 | 2008-11-20 | Acides biphenyl carboxyliques substitutes et derives en resultant. |
Country Status (35)
Country | Link |
---|---|
US (1) | US7557244B2 (fr) |
EP (2) | EP1849762B1 (fr) |
JP (1) | JP5479088B2 (fr) |
KR (1) | KR101542255B1 (fr) |
CN (1) | CN101687758B (fr) |
AP (1) | AP2008004656A0 (fr) |
AR (1) | AR060568A1 (fr) |
AU (1) | AU2007240335B2 (fr) |
BR (1) | BRPI0710656A2 (fr) |
CA (1) | CA2650006C (fr) |
CR (2) | CR10375A (fr) |
CY (1) | CY1109399T1 (fr) |
DE (1) | DE602006007810D1 (fr) |
DK (1) | DK1849762T3 (fr) |
EA (1) | EA016129B9 (fr) |
ES (2) | ES2328616T3 (fr) |
GE (1) | GEP20115269B (fr) |
GT (1) | GT200900120A (fr) |
IL (2) | IL194852A0 (fr) |
MA (1) | MA30475B1 (fr) |
MX (1) | MX2008013445A (fr) |
MY (1) | MY148953A (fr) |
NO (1) | NO20084517L (fr) |
NZ (1) | NZ573000A (fr) |
PE (1) | PE20080364A1 (fr) |
PL (1) | PL1849762T3 (fr) |
PT (1) | PT1849762E (fr) |
SI (1) | SI1849762T1 (fr) |
SM (1) | SMP200800061B (fr) |
TN (1) | TNSN08413A1 (fr) |
TW (1) | TWI399362B (fr) |
UA (1) | UA95952C2 (fr) |
UY (1) | UY30301A1 (fr) |
WO (1) | WO2007124394A1 (fr) |
ZA (1) | ZA200809856B (fr) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101903335A (zh) * | 2007-10-19 | 2010-12-01 | 詹森药业有限公司 | 连接有胺的γ-分泌酶调节剂 |
BRPI0818773A2 (pt) | 2007-10-19 | 2015-04-14 | Janssen Pharmaceutica Nv | Moduladores de gama-secretase ligados a carbono |
AU2008312362A1 (en) * | 2007-10-19 | 2009-04-23 | Janssen Pharmaceutica, N.V. | Gsm intermediates |
CN101903347B (zh) | 2007-10-19 | 2013-03-27 | 詹森药业有限公司 | 带哌啶基和哌嗪基的γ-分泌酶调节剂 |
US20110092554A1 (en) * | 2007-11-19 | 2011-04-21 | Richard Chesworth | 1,3,5 tri-subtituted benzenes for treatment of alzheimer's disease and other disorders |
CA2710477A1 (fr) | 2007-12-20 | 2009-07-09 | Envivo Pharmaceuticals, Inc. | Benzenes tetrasubstitues |
WO2011046774A1 (fr) * | 2009-10-16 | 2011-04-21 | Merck Sharp & Dohme Corp. | Dérivés d'éther diarylique comme inhibiteurs de la gamma-sécrétase n'agissant pas sur la voie notch |
US8785481B2 (en) | 2010-09-29 | 2014-07-22 | Merck Sharp & Dohme Corp. | Ether benzotriazole derivatives |
WO2012119035A1 (fr) * | 2011-03-03 | 2012-09-07 | Treventis Corporation | Composés anti-amyloïdes et procédés |
WO2015109109A1 (fr) | 2014-01-15 | 2015-07-23 | Forum Pharmaceuticals Inc. | Morpholino-pyrimidines fusionnées et leurs procédés d'utilisation |
WO2016201168A1 (fr) | 2015-06-10 | 2016-12-15 | Forum Pharmceuticals Inc. | Composés oxadiazine et leurs méthodes d'utilisation |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5877399A (en) | 1994-01-27 | 1999-03-02 | Johns Hopkins University | Transgenic mice expressing APP-Swedish mutation develop progressive neurologic disease |
JP3802581B2 (ja) * | 1995-03-01 | 2006-07-26 | 富山化学工業株式会社 | 新規なビフェニル誘導体またはその塩およびそれらを含有する抗炎症剤 |
AU2001257022B2 (en) | 2000-04-13 | 2005-02-03 | Mayo Foundation For Medical Education And Research | Abeta 42 lowering agents |
DE10131899A1 (de) | 2001-07-04 | 2003-02-27 | Boehringer Ingelheim Pharma | In vitro-Screening-Assay für gamma-Secretase |
BR0311788A (pt) * | 2002-06-27 | 2005-03-15 | Fujisawa Pharmaceutical Co | Composto derivado aminoalcoólico, processo para sua preparação, composição farmacêutica, compreendendo o mesmo, seu uso e método de tratamento |
GB0305918D0 (en) * | 2003-03-14 | 2003-04-23 | Glaxo Group Ltd | Novel compounds |
WO2005110963A1 (fr) * | 2004-05-19 | 2005-11-24 | Cellzome Ag | Acides (biphenyl-3-yl)-carboxyliques et derives de ceux-ci ainsi que leur utilisation en therapie |
GB0416508D0 (en) * | 2004-07-23 | 2004-08-25 | Merck Sharp & Dohme | Therapeutic agents |
JPWO2006022237A1 (ja) * | 2004-08-24 | 2008-05-08 | キッセイ薬品工業株式会社 | 脂肪肝の予防または治療剤 |
EP1937632A1 (fr) * | 2005-10-06 | 2008-07-02 | Astra Zeneca AB | Nouveaux composes |
-
2006
- 2006-04-21 PL PL06112938T patent/PL1849762T3/pl unknown
- 2006-04-21 EP EP06112938A patent/EP1849762B1/fr not_active Not-in-force
- 2006-04-21 PT PT06112938T patent/PT1849762E/pt unknown
- 2006-04-21 DE DE602006007810T patent/DE602006007810D1/de active Active
- 2006-04-21 SI SI200630391T patent/SI1849762T1/sl unknown
- 2006-04-21 DK DK06112938T patent/DK1849762T3/da active
- 2006-04-21 ES ES06112938T patent/ES2328616T3/es active Active
-
2007
- 2007-04-20 GE GEAP200710983A patent/GEP20115269B/en unknown
- 2007-04-20 MX MX2008013445A patent/MX2008013445A/es active IP Right Grant
- 2007-04-20 AR ARP070101725A patent/AR060568A1/es not_active Application Discontinuation
- 2007-04-20 MY MYPI20084201A patent/MY148953A/en unknown
- 2007-04-20 KR KR1020087028566A patent/KR101542255B1/ko not_active IP Right Cessation
- 2007-04-20 US US11/737,938 patent/US7557244B2/en not_active Expired - Fee Related
- 2007-04-20 EP EP07760976A patent/EP2021314B1/fr active Active
- 2007-04-20 ES ES07760976T patent/ES2400530T3/es active Active
- 2007-04-20 CN CN200780018586.2A patent/CN101687758B/zh not_active Expired - Fee Related
- 2007-04-20 PE PE2007000496A patent/PE20080364A1/es active IP Right Grant
- 2007-04-20 WO PCT/US2007/067039 patent/WO2007124394A1/fr active Application Filing
- 2007-04-20 UA UAA200813476A patent/UA95952C2/ru unknown
- 2007-04-20 SM SM200800061T patent/SMP200800061B/it unknown
- 2007-04-20 BR BRPI0710656-4A patent/BRPI0710656A2/pt not_active IP Right Cessation
- 2007-04-20 AP AP2008004656A patent/AP2008004656A0/xx unknown
- 2007-04-20 CA CA2650006A patent/CA2650006C/fr not_active Expired - Fee Related
- 2007-04-20 AU AU2007240335A patent/AU2007240335B2/en not_active Ceased
- 2007-04-20 TW TW096114160A patent/TWI399362B/zh not_active IP Right Cessation
- 2007-04-20 NZ NZ573000A patent/NZ573000A/en not_active IP Right Cessation
- 2007-04-20 JP JP2009506782A patent/JP5479088B2/ja not_active Expired - Fee Related
- 2007-04-20 UY UY30301A patent/UY30301A1/es unknown
- 2007-04-20 EA EA200802172A patent/EA016129B9/ru not_active IP Right Cessation
-
2008
- 2008-10-17 CR CR10375A patent/CR10375A/es not_active Application Discontinuation
- 2008-10-17 TN TNP2008000413A patent/TNSN08413A1/en unknown
- 2008-10-22 IL IL194852A patent/IL194852A0/en unknown
- 2008-10-22 IL IL194790A patent/IL194790A/en not_active IP Right Cessation
- 2008-10-27 NO NO20084517A patent/NO20084517L/no not_active Application Discontinuation
- 2008-11-19 ZA ZA200809856A patent/ZA200809856B/xx unknown
- 2008-11-20 MA MA31395A patent/MA30475B1/fr unknown
- 2008-11-21 CR CR10451A patent/CR10451A/es not_active Application Discontinuation
-
2009
- 2009-05-11 GT GT200900120A patent/GT200900120A/es unknown
- 2009-09-21 CY CY20091100982T patent/CY1109399T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA30475B1 (fr) | Acides biphenyl carboxyliques substitutes et derives en resultant. | |
MA29514B1 (fr) | Acides carboxylique (biphenyle) et leurs derives | |
DE60124085D1 (de) | Pde-v hemmer zur behandlung von morbus parkinson | |
MA27472A1 (fr) | Acetyle 2-hydroxy-1, 3 diaminoalcanes | |
ATE517861T1 (de) | Benzylether und benzylaminoverbindungen als inhibitoren von beta-secretase zur behandlung von alzheimer-krankheit | |
MA30420B1 (fr) | Derives de terphenyle pour le traitment de la maladie d'alzheimer | |
EA200800975A1 (ru) | ПИРИМИДИНИЛАМИДНЫЕ СОЕДИНЕНИЯ (ВАРИАНТЫ), ВКЛЮЧАЮЩАЯ ИХ ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ И СПОСОБ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЯ, ОПОСРЕДОВАННОГО α4-ИНТЕГРИНАМИ | |
EA201001585A1 (ru) | Производные тиенопиридона в качестве активаторов амр-активированной протеинкиназы (амрк) | |
ATE506951T1 (de) | Als inhibitoren von beta-secretase aktive tertiäre carbinamine mit substituierten heterocyclen zur behandlung der alzheimer- krankheit | |
MA30694B1 (fr) | Derives de n-(amino-heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique. | |
MA30402B1 (fr) | Acides carboxyliques substitues par des phenylamino-benzoxazoles, leur procede de production et leur utilisation comme medicaments | |
ATE538651T1 (de) | Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit | |
EA201000884A1 (ru) | Производные 1,2-дизамещенного 4-бензиламинопирролидина в качестве ингибиторов белка-переносчика холестерилового эфира, используемые для лечения заболеваний, таких как гиперлипидемия или артериосклероз | |
CY1107956T1 (el) | Χρηση υποκατεστημενων 2-αμινοτετραλινιων για την προληπτικη αντιμετωπιση της νοσου του παρκινσον | |
EP1817312A4 (fr) | Inhibiteurs de l'aminopyridyle de la beta-secretase macrocyclique permettant de traiter la maladie d'alzheimer | |
CN1283183A (zh) | 具有mmp和tnf抑制活性的异羟肟酸和羧酸衍生物 | |
MA29464B1 (fr) | Methode de preparation d'acides 1,6-dihydro-6-oxo-4-pyrimidinecarboxyliques eventuellement 2-substitues | |
MA28562B1 (fr) | 1,3,4-oxadiazol-2-ones comme modulateurs de ppar delta et leur utilisation | |
TN2009000483A1 (fr) | Derives de 7-alkynyl-1-8-naphthyridones, leur preparation et leur application en therapeutique | |
DE60326232D1 (de) | Verwendung von substituierten cyanopyrrolidinen zur behandlung von hyperlipidämie | |
TN2009000470A1 (fr) | Derives d'azetidine et leur utilisation comme antagonistes de prostaglandine e2 | |
ATE409693T1 (de) | Verfahren zur herstellung von 2-(4- chlorbenzoylamino-3- 2(1h)-chinolinon-4-yl propionsäure | |
ATE357453T1 (de) | Comt-inhibitoren | |
ATE538796T1 (de) | Piperidin- und pyrrolidin-beta-secretase-hemmer zur behandlung von alzheimer-krankheit | |
MA33917B1 (fr) | Dérivés d'acide carboxylique ayant un cycle oxazolopyrimidine 2,5-substitue |